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INTRODUCTION
 Sepsis has been a major cause of mortality and 
morbidity worldwide. It is the leading cause of 
death overall and is the most common cause of shock 
in the United States.1,2 Despite recent advances in 
diagnosis and management, mortality from sepsis 
remains high, ranging from 15% in patients with 
sepsis to 40-50% in patients with septic shock with 
multi-organ dysfunction syndrome (MODS).3 It 
has been observed that hormonal differences may 
play a role in development of chronic autoimmune 
and inflammatory diseases such as multiple 
sclerosis, lupus, or rheumatoid arthritis in women.4 
Studies have shown that the immune response to 
infection as well as the incidence of sepsis differs 
between sexes.5 Data from animal studies suggests 
that females have advantageous immunologic 
responses during infections.6 Epidemiologic 
studies consistently report higher sepsis incidence 
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ABSTRACT
Background and Objective: Sepsis remains a leading cause of death across the world, carrying a mortality 
rate of 20–50%. Women have been reported to be less likely to suffer from sepsis and to have a lower risk 
of mortality from sepsis compared to men. The objective of this study was to determine the relationship 
between gender and mortality in sepsis, and compare cytokine profiles of male and female patients.
Methods: This was a prospective case series on 97 patients admitted with sepsis. Clinical and microbiological 
data was gathered, blood samples were collected for cytokine (IL-10, IL-6 and TNFa) levels and patients 
were followed up for clinical outcome. 
Results: There were 54% males and 46% females, with no significant difference of age or comorbids 
between genders. Respiratory tract infection was the commonest source of sepsis, and was more common 
in females (60%) compared to males (39%) (p=0.034). Males had a higher mortality (p=0.048, RR 1.73) and 
plasma IL-6 level(p=0.040) compared to females. Mean IL-6 plasma level was significantly (p<0.01) higher 
in patients who died vs. who recovered.
Conclusion: Our study shows that males with sepsis have a 70% greater mortality rate, and mortality is 
associated with a higher IL-6 plasma level.
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in males.7,8 However, the influence of gender on 
severe infections is still highly controversial and 
although animal studies have indicated a survival 
advantage for females,6 it seems to be contradictory 
to human clinical data on sepsis related mortality. 
Eachempati et al.9 has highlighted that female 
gender as an independent predictor of increased 
mortality in patients with documented infection in 
a surgical intensive care unit (ICU). Hence the data 
seen in sepsis patients with respect to differences in 
outcomes in relation to gender has so far has been 
equivocal.
 This study is part of a larger study to evaluate 
the characteristics of sepsis patients and its purpose 
is to study the relationship between gender and 
mortality due to sepsis and to identify differences 
if any between the cytokine levels specifically IL-6, 
IL-10 and TNF alpha between the genders.
METHODS
 We conducted a prospective observational study 
at Aga Khan University Hospital, Karachi, between 
2005 and 2006. The study was approved by the 
Ethics Review Committee of Aga Khan University, 
and we recruited patients from the hospital clinical 
areas after obtaining informed consent. A total of 
100 patients of age >18 years, admitted with sepsis 
and septic shock as defined by Society of Critical 
Care Medicine SCCM were included. Sepsis was 
defined as presence of infection along with presence 
of two out of following four parameters: body 
temperature higher than 38°C or lower than 36°C, 
heart rate higher than 90/min, hyperventilation 
evidenced by respiratory rate higher than 20/min 
or PaCO2 lower than 32 mmHg and white blood 
cell count higher than 12,000 cells/μl or lower 
than 4,000/μl. Patients with moderate, severe or 
life threatening infection s were included. Life 
threatening infection was defined as presence of 
septic shock, and was severe infection if patient 
had severe sepsis with presence of lactic acidosis 
and hypotension of SBP <90 or SBP Drop ≥ 40 mm 
Hg of normal which was responding to IV fluids 
and moderately severe infection which fulfilled the 
criteria of sepsis and required hospital admission 
and use of intravenous antimicrobial therapy. 
Patients with systemic inflammatory response 
syndrome (SIRS) but not having any infection were 
excluded. Clinical and microbiological data was 
gathered on a proforma. Variables studied included 
age, gender, co-morbids, site of infection, microbial 
pathogen isolated and outcome measures included 
in-hospital mortality as opposed to recovery and 
discharge. Types of infection studied included lower 
respiratory tract infection including community 
acquired pneumonia and health care associated 
pneumonia, urinary tract infections including 
catheter associated UTI, intra-abdominal infections 
including abscesses and peritonitis, skin and soft 
tissue infections, bloodstream infections including 
central line associated bloodstream infections, 
central nervous system infections, genitourinary 
infections and septic arthritis and osteomyelitis 
patients were followed up for clinical outcome.
Blood sample collection: Blood samples were 
collected in EDTA tube. The plasma was separated 
by centrifugation @ 2000rpm for 10mins. Clear 
supernatant was collected and stored at -80°C until 
use.
Cytokine ELISA: Cytokine (IL-10, IL-6 and TNFa) 
levels were measured using ELISA. Briefly, 
Immulon 4 plates were coated with capture antibody 
specific for the human TNFa, IL6, and IL10 and 
incubated overnight at 4˚C. Non-specific binding 
sites were blocked with 3% bovine serum albumin 
(BSA) in phosphate buffer saline (PBS) for 2 hour 
at room temp. Neat Plasma samples were added 
in respective wells according to plate template. A 
dose response curve starting from 1000-7.8 pg/ml 
for every cytokine was run simultaneously with 
samples. Plates were further incubated overnight 
at 4˚C. Next day, the captured cytokines was then 
incubated with biotinylated probing antibodies 
specific for the cytokine to be detected. The revealing 
probe was avidin bound to horseradish peroxidase 
(HRP) were used as conjugate. The plates were 
washed three times in between each incubation, 
with PBS containing 0.05% Tween-20 to remove any 
unbound protein. The plates were finally developed 
for color reaction using OPD tablets @ 2mg/ml in 
Na perborate buffer. The intensity of color reaction 
is proportional to amount of cytokine present in 
serum. All plates were read on Biorad at 450 nm.
Statistical analysis: Data was analyzed on SPSS. 
Numerical variables were expressed as mean ± 
standard error of the mean. Chi square or Fisher 
exact test was used for group comparisons of 
categorical variables and Mann Whitney test U for 
continuous variables. P-value < 0.05 was considered 
significant.
RESULTS
 Out of 100 patients with sepsis, 97 were included 
for analysis, exclusions being due to incomplete 
information. 54% were male and 46% female. The 
age distribution was similar in both the genders 
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with mean age being 54±2 years in males and 50±2 
in females (p=0.30). Diabetes mellitus was the 
leading co-morbid present in 21 males as opposed 
to 18 females, followed by hypertension in 22 males 
and females respectively. There were no significant 
differences among gender for co-morbids (Table-I). 
Respiratory tract infection was the most common 
source of sepsis, and was significantly more 
common in females compared to males (60% vs. 39% 
respectively, p=0.034). Urinary tract infection was 
the next common source but no gender difference 
was observed (Table-I). Gram negative organisms 
accounted for about 60% of the infections in both 
genders and E.coli was identified as the most 
frequent pathogen cultured from various sites in 
both the sexes (22%). Septic shock was present in 16 
males and 13 females.
 As for outcome, males had a significantly greater 
mortality compared to females (46% vs. 27%, 
p=0.048) (Fig.1), with relative risk (RR) of 1.73 
(0.98 <RR< 3.05). On categorizing patients into two 
groups based on age >50 years and < 50 years, no 
significant difference was observed in mortality. 
Mean plasma level of TNFa was 193.15±61.92 pg/
ml in males and 91.44±20.80pg/ml in females but 
this was not statistically significant (p=0.972). 
Similar to TNFa, mean plasma level of IL-10 was 
also not significantly different (p=0.940) between 
genders, i.e. 188.26±51.47 pg/ml in males and 164.29 
±34.25pg/ml in females. However, mean plasma 
level of IL-6 was 60.72±13.41 pg/ml in males and 
28.06±7.16 pg/ml in females which was two-fold 
higher in males compared to females (p=0.025, 
Mann Whitney U test). Notably, mean IL-6 plasma 
level was also significantly (P<0.01) higher in 
patients who died vs. who recovered (Fig.2).
Gender and mortality from sepsis
Table-I: Comparison of patient characteristics between genders (n,%).
 Male (n=52) Female (n=45) P-value
Age in years (mean±SD ) 54±17 50±16 0.300
Sepsis on admission 36 (69%) 32 (71%) 0.840
Septic shock on admission 16 (31%) 13 (29%) 0.840
Co-morbids
Diabetes mellitus 21 (40%) 18 (40%) 0.969
Hypertension 22 (42%) 22 (49%) 0.516
Ischemic heart disease 11 (21%) 11 (24%) 0.670
Chronic renal disease 12 (23%) 12 (27%) 0.683
Chronic liver disease 5 (10%) 1 (2%) 0.211
Type of infection
Lower respiratory tract Infection 20 (38%) 27 (60%) 0.034
Urinary tract infection including CAUTI 17 (33%) 20 (44%) 0.235
Bloodstream infection including CLABSI 11 (21%) 14 (31%) 0.264
Intra-abdominal infection 5 (10%) 0 (0%) 0.033
Skin & soft tissue Infection 4 (8%) 4 (9%) 0.831
CNS infection 2 (4%) 4 (9%) 0.304
Others 9 (17%) 6 (13%) 0.589
Microbiological Data
Culture Positive 26 (50%) 23 (51%) 0.913
Gram positive organisms isolated 8 (15%) 6 (13%) 0.774
Gram negative organisms isolated 15 (29%) 14 (31%) 0.808
Polymicrobial growth 3 (6%) 3 (7%) 0.855
Fig.1: Bar chart comparing proportion of male and 
female patients expired and recovered. Difference
 was significant (p=0.048, Chi square test).
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 As gender and IL-6 levels had significant 
relationship with mortality, to determine possible 
interdependency of these variables with comorbids 
and site of infection, logistic regression analysis 
was performed. The results (Table-III) showed 
that gender is related to mortality independent of 
other factors. Moreover, urinary and respiratory 
tract infections, and IL-6 levels were independently 
associated with mortality. Comorbids (diabetes 
and ischaemic heart disease) did not have an 
independent relation to mortality.
DISCUSSION
 Our study has shown greater mortality among 
males as compared to females with sepsis. This 
phenomena had been observed in animal studies 
where females have been known to have survival 
advantage in terms of both immunologic as well as 
cardiovascular responses.6,10 However, most clinical 
studies have failed to show consistent differences 
in sepsis outcomes in relation with gender. 
Eachempati et al.9 has highlighted that female 
gender as an independent predictor of increased 
mortality in patients with documented infection 
in a surgical intensive care unit (ICU). A study on 
patients admitted in intensive care showed slight 
higher odds of mortality in females versus males 
(OR 1.11) in the subgroup with severe sepsis.11 
They performed multivariate analysis to show 
that gender had independent effect on mortality, 
analysis showed higher mortality in females with 
severe sepsis. This is in contrast to our study, where 
males had higher mortality. The difference may 
be due to differences in the patient population. 
Nosheen Nasir et al.
Table-II: Comparison of microbiological and cytokine data and outcome between genders.
 Male (n=52) Female (n=45) P-value
Microbiological Data (n,%)   
Culture Positive 26 (50%) 23 (51%) 0.913
Gram positive organisms isolated 8 (15%) 6 (13%) 0.774
Gram negative organisms isolated 15 (29%) 14 (31%) 0.808
Polymicrobial growth 3 (6%) 3 (7%) 0.855
Cytokines (pg/ml; mean±SD)   
TNFα 193.15±61.92 91.44±20.80 0.972
Interleukin 6 60.72±13.41 28.06±7.16 0.025
Interleukin 10 188.26±51.47 164.29±34.25 0.940
Outcome (n,%)   
Expired 24 (46.2%) 12 (26.7%) 0.048
Recovered 28 (53.8%) 33 (73.3%)
Table-III: Multivariate analysis using logistic 
regression with mortality as dependent variable. 
Gender, two sites of infection (respiratory 
and urinary tracts) and plasma IL-6 were 





Ischaemic heart disease 0.367
Respiratory tract infection 0.006
Urinary tract infection 0.029
Plasma IL-6 level 0.016
Fig.2: Box plot showing median (50%), 25% and 75% 
quartiles of IL6 (pg/ml) values in male and females 
patients in both expired (n=36) and recovered (n=61) 
categories. The IL6 levels were determined using an in-
house sandwich ELISA assay in serum samples (dilution 
factor). All samples were run in duplicate and mean 
values of individual samples were entered in SPSS 13.0 for 
analysis. Difference of mean values between expired and 
recovered categories within the genders was significant 
at p<0.05, Mann Whitey U test.
Similarly, a study from Germany concluded that 
there were no differences in patients’ outcome 
related to gender aspect in mainly surgical ICUs. 
However, for patients with sepsis, an increase 
of mortality is related to the female sex.12 On the 
other hand Wichmann et al.13 concluded from 
his study that a significantly smaller number of 
female patients requiring intensive care as well as a 
significantly lower incidence of severe sepsis/septic 
shock in female intensive care patients. Despite 
these findings mortality from severe sepsis/ septic 
shock was not affected by gender. This is in contrast 
to our finding where male patients were at a greater 
risk for dying from sepsis. These differences may be 
due to surgical ICU setting which was studied by 
Nachtigall et al.12 and Wichmann et al.13 as opposed 
to our ICU where there is representation from both 
surgical and medical patients. However, one of our 
limitations is a small sample size and perhaps a 
large sample is needed for better evaluation of the 
difference observed. One of the probable reasons is 
the accessibility and priority of males to be admitted 
in hospital compared to females.
 Moreover role of cytokines has been extensively 
studied in order to gain better insight into the 
processes that influence outcome in sepsis. Multiple 
organ dysfunction is due to a severe inflammatory 
reaction resulting from systemic cytokine release.14 
The pro-inflammatory reaction is mediated by 
tumor necrosis factor (TNF-a), interleukin (IL) 
1 and IL-6. The body also mounts an immediate 
anti-inflammatory response largely mediated by 
IL-10.15 In a prospective study from Germany, 
gender differences in patients with surgical sepsis 
were evaluated in terms of survival, sex hormones, 
and proinflammatory as well as anti-inflammatory 
mediators. The study demonstrated a significantly 
better prognosis for women, which may be related 
to increased levels of anti-inflammatory mediator 
IL-10.16 Although our study also showed better 
outcome in women but there was no statistically 
significant difference in IL-10 levels in either 
group with a trend towards higher level in men as 
compared to women. Schroder et al.16 also observed 
sustained elevation of IL-6 level in patients with 
multiple organ dysfunction and a high mortality 
rate but there was no difference between women 
and men whereas bioactivity of TNF-a increased 
continuously in men as opposed to low levels in 
women. This is in contrast to our finding where 
IL-6 was associated with overall greater mortality 
and was significantly higher in men. This could 
reflect differences in population being studied. 
   Pak J Med Sci   2015   Vol. 31   No. 5      www.pjms.com.pk   1205
Gender and mortality from sepsis
In our study, women had; significantly higher 
frequency of respiratory tract infection. However 
a multicenter study from 3 different countries has 
shown greater incidence of respiratory infections in 
men as compared to women.11 These findings may 
need to be better evaluated in a study with large 
sample size.
 As to the possible reasons why our study 
showed a higher mortality rate in men compared 
to women, our data raises several possibilities: 
1) men had higher level of IL-6 in our study and 
other studies have shown that high IL-6 is related 
to higher mortality,16 2) there may be differences in 
accessibility to intensive care in our socio-cultural 
set up where males may get preference when they 
are more sick, 3) nature of patients in our ICU, 
which is a combined medical and surgical ICU, may 
be different from other studies.
 A limitation of our study is that we were unable 
to use predictive scores such as APACHE. Such 
scores are generally applied in the ICU setting 
while, many of our patients were not admitted in 
ICU. Several parameters used for such scores were 
not available in all our patients, e.g. arterial blood 
gases, bilirubin, hourly urine output. Moreover, the 
relatively small sample size is another limitation; a 
larger sample size may have permitted meaningful 
subgroup analyses.
CONCLUSION
 We have found that males with sepsis have a 70% 
greater mortality rate as compared to females. This 
higher mortality appears to be related to differences 
in respiratory tract infection rate and IL-6 plasma 
levels, between the genders.
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